Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
April 6-21, 1987
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Relatively well reported study.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1987
Report date:
1987

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
GLP compliance:
yes
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Reference substance name:
Acetic acid, oxo-, sodium salt, reaction products with cresol and ethylenediamine, iron sodium salts
EC Number:
283-041-9
EC Name:
Acetic acid, oxo-, sodium salt, reaction products with cresol and ethylenediamine, iron sodium salts
Cas Number:
84539-53-7
Molecular formula:
non specified (UVCB substance)
IUPAC Name:
non specified (UVCB substance)
Details on test material:
- Name of test material (as cited in study report): Bolikel FE
- Physical state: brown/red crystalline powder
- Lot/batch No.: Batch No. 2
- Storage condition of test material: ambient temperature, under dry conditions
- Other: received on February 27, 1987 (4 x 375 g)

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River (U.K) Limited, Margate, Kent, England
- Age at study initiation: young adult rats, approximately 5 weeks old
- Weight at study initiation: (pre-fasted) males 110 - 117 g; females 97 - 110 g.
- Fasting period before study: approximately 18 hours before administration of test material
- Housing: 5 animals of the same sex (in type RCI cages with stainless steel grid floors)
- Diet (e.g. ad libitum): fed without restriction (Laboratory animal diet no. 1 from Labsure, Manea, Cambridgeshire, England)
- Water (e.g. ad libitum): free access to tap water
- Acclimation period: at least 6 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 (range 18 - 25)
- Humidity (%): 55 (range 40 - 70)
- Air changes (per hr): 15 complete air changes per hour, without re-circulation
- Photoperiod (hrs dark / hrs light): 12 hours of artificial light per day

IN-LIFE DATES: From: April 6, 1987 To: April 21, 1987

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 25% w/v formulation in distilled water (250 mg/mL)
- Justification for choice of vehicle: not indicated

MAXIMUM DOSE VOLUME APPLIED: 20 mL/kg
Doses:
Dose: 5000 mg/kg
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days (terminated on Day 15)
- Frequency of observations and weighing: Three separate inspections were made during the first hour after administration and two further inspections during the remainder of Day 1. From Day 2 onwards, the animals were inspected twice daily. The type, time of onset and duration of reactions to treatment were recorded. The bodyweight of each animal was recorded on the day before dosing and on Days 1, 8 and 15. The test was terminated on Day 15.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, macroscopic pathology
Statistics:
Not applicable

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 5 000 mg/kg bw
Based on:
test mat.
Mortality:
One female rat died during the first overnight period. There were no other deaths.
Clinical signs:
other: Decreased motor activity, hunched posture, piloerection and urinogenital staining from purple urine were observed in all rats during the first five hours after dosing. Surviving rats were ungroomed on Day 2, but all had fully recovered by Day 3 and remain
Gross pathology:
Necropsy of the decedent revealed fur staining, abnormal gastro-intestinal contents and extensive cannibalisation. Necropsy of the surviving rats revealed red staining of the perineum or ventral surface of several animals and less frequent observations of altered gastro-intestinal contents or dark lungs.

Applicant's summary and conclusion

Interpretation of results:
study cannot be used for classification
Remarks:
Migrated information
Conclusions:
The acute oral median lethal dose to rats of Bolikel FE was found to be greater than 5000 mg/kg bodyweight. According to OECD-GHS Bolikel FE is not classified.
Executive summary:

The study was performed according to OECD Guideline 401 (Acute Oral Toxicity) and according to GLP standards.

The test material, Bolikel FE was evaluated in a limit test for its acute oral toxicity potential in rats when administered as a gavage dose at a level of 5000 mg/kg to a group of 5 males and 5 females. One female rat died during the first overnight period. Clinical signs of toxicity included decreased motor activity, hunched posture, pilo-erection and urinogenital staining from purple urine; recovery was complete on Day 3. Gross pathologic examination at termination revealed red staining of the perineum or ventral surface of several animals and less frequent observations of altered gastro-intestinal contents or dark lungs.

The acute oral median lethal dose to rats of Bolikel FE was found to be greater than 5000 mg/kg bodyweight. According to OECD-GHS Bolikel FE is not classified.